Some Implications of Receptor Kinase Signaling Pathway for Development of Multitargeted Kinase Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1874-4729|6|1|48-55

ISSN： 1874-4710

Source： Current Radiopharmaceuticals, Vol.6, Iss.1, 2013-03, pp. : 48-55

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

3D-QSAR Studies of Various Diaryl Urea Derivatives of Multi-targeted Receptor Tyrosine Kinase Inhibitors: Molecular Field Analysis Approach

By  

Letters in Drug Design & Discovery, Vol. 5, Iss. 7, 2008-10 ,pp. : 437-448

Bentham Science Publishers

Access to resources Recommend Favorite

The PI3 Kinase Signaling Pathway in Prostate Cancer

By  

Current Cancer Drug Targets, Vol. 13, Iss. 2, 2013-02 ,pp. : 157-164

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of the Sphingosine Kinase Pathway as Potential Therapeutics

By  

Current Cancer Drug Targets, Vol. 10, Iss. 4, 2010-06 ,pp. : 354-367

Bentham Science Publishers

Access to resources Recommend Favorite

Peptides as Signaling Inhibitors for Mammalian MAP Kinase Cascades

By  

Current Pharmaceutical Design, Vol. 15, Iss. 21, 2009-07 ,pp. : 2471-2480

Bentham Science Publishers

Access to resources Recommend Favorite

Modulation of the Fce Receptor I Signaling by Tyrosine Kinase Inhibitors: Search for Therapeutic Targets of Inflammatory and Allergy Diseases

By  

Current Pharmaceutical Design, Vol. 10, Iss. 15, 2004-06 ,pp. : 1727-1737

Bentham Science Publishers

Access to resources Recommend Favorite